[High dose vitamin C inhibits proliferation of breast cancer cells through reducing glycolysis and protein synthesis]
/in Unkategorisiert /von root[High dose vitamin C inhibits proliferation of breast cancer cells through reducing glycolysis and protein synthesis]
/in Unkategorisiert /von rootProfessor Volker Schirrmacher vom Kölner IOZK eröffnet die Tagung an der Universität zu Kiel mit seinem Vortrag zur Erforschung onkolytischer Viren im Zusammenhang der individuellen Krebs-Immuntherapie.
/in IOZK bei Fachtagungen /von IOZKPhase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer
/in Colorectal Cancer, Gastric Cancer, International Publications, Micronutrients /von 2019-05-16 / 2019 May;19(1):460Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma, a phase II single centre open-label clinical trial: rationale and design of the MESOPEC trial
/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2019-05-14 / BMJ Open 2019 05;9(5):e026779Whole-body hyperthermia in combination with systemic therapy in advanced solid malignancies
/in Hyperthermia, International Publications /von 2019-05-02 / Crit. Rev. Oncol. Hematol. 2019 Jul;139:67-74Targeting cancer vulnerabilities with high-dose vitamin C
/in International Publications, Micronutrients /von 2019-05-01 / Nat. Rev. Cancer 2019 05;19(5):271-282
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de